Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Obstetrics/Gynecology

Obstetrics/Gynecology: market research reports

Find the information you need on obstetrics/gynecology industry. Our collection of research reports provides insights into gynecological therapy advances and market trends, analysis, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.

Obstetrics/Gynecology market research reports and industry analysis

Metastatic Ovarian Cancer – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Metastatic Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Ovarian Cancer. Metastatic Ovarian Cancer ... \| read more...	$2,000.00
Ovarian Cancer Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... an important secondary indication for existing and pipeline drugs. There are today 220 companies plus partners developing 306 drugs targeting ovarian cancer in development. In addition, there are 8 suspended drugs and the accumulated number ... \| read more...	$5,621.25
Post Menopausal Osteoporosis – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post Menopausal Osteoporosis. Post Menopausal Osteoporosis ... \| read more...	$2,000.00
Uterine Cancer – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Uterine Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uterine Cancer. Uterine Cancer - Pipeline Review, Half Year ... \| read more...	$2,000.00
Female Hypoactive Sexual Desire Disorder – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
2013 Analysis of the Pap Smear/HPV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ... \| read more...	$4,350.00
Ovarian Cancer – Pipeline Review, H1 2013 4/10/2013 \| published by: Global Markets Direct ... for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Cancer. Ovarian Cancer - Pipeline Review, Half Year ... \| read more...	$2,500.00
EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022 3/31/2013 \| published by: GlobalData ... the health of these tissues and structures, a lack of which causes them to undergo atrophy (Castelo-Branco and Rostro, 2007; Nappi and Kokot-Kierepa, 2012). During the menopause transition and postmenopausal periods, women can experience a ... \| read more...	$3,995.00
Female Sexual Dysfunction – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Sexual Dysfunction. Female Sexual Dysfunction ... \| read more...	$2,000.00
Menopausal Disorders – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Disorders. Menopausal Disorders - Pipeline Review, Half Year ... \| read more...	$2,000.00
Uterine Fibroids – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... for Uterine Fibroids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uterine Fibroids. Uterine Fibroids - Pipeline Review, Half Year ... \| read more...	$2,000.00
Menopausal Hot Flashes – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. Menopausal Hot Flashes ... \| read more...	$2,000.00
Cervical Dysplasia – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Dysplasia. Cervical Dysplasia - Pipeline Review, Half Year ... \| read more...	$2,000.00
Vaginal Atrophy (Atrophic Vaginitis) – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vaginal Atrophy (Atrophic ... \| read more...	$2,000.00
Human Papillomavirus Infections – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Human Papillomavirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections. Human Papillomavirus Infections - ... \| read more...	$2,000.00
2013 U.S. Patient care - Pregnancy/childbirth sold through Offices of physicians-Product & Services Report 3/15/2013 \| published by: Barnes Reports ... The report features 2013 current and 2014 forecast estimates on the sales of Patient care - Pregnancy/childbirth sold through Offices of physicians nationally and for all 50 U.S. States and up to 900 metro areas. \| read more...	$199.00
Epithelial Ovarian Cancer – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... development for Epithelial Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Epithelial Ovarian Cancer. Epithelial Ovarian Cancer - ... \| read more...	$2,000.00
Endometriosis – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Endometriosis. Endometriosis - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Fallopian Tube Cancer – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... development for Fallopian Tube Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fallopian Tube Cancer. Fallopian Tube Cancer - ... \| read more...	$2,000.00
Endometrial Cancer – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Endometrial Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Endometrial Cancer. Endometrial Cancer - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Women Infertility – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Women Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Women Infertility. Women Infertility - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Vulvovaginal Candidiasis – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Vulvovaginal Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vulvovaginal Candidiasis. Vulvovaginal Candidiasis - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Cervical Cancer – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Cervical Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Cancer. Cervical Cancer - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Dysmenorrhea – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dysmenorrhea. Dysmenorrhea - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
The 2013-2018 Outlook for Disposable Surgical Drapes and Packs for Obstetric and Operating Rooms in the United States 1/9/2013 \| published by: Icon Group International, Inc. ... or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States ... \| read more...	$495.00

< prev 1 2 3 4 5 6 7 8 9 10 next >